KMID : 0371919890020010025
|
|
Journal of Wonju College of Medicine 1989 Volume.2 No. 1 p.25 ~ p.32
|
|
In Vitro Susceptibility of Cryptococcus neoformans to Amphotericin B, 5-Fluorocytosine, Ketoconazole, Miconazole and Rifampicin Alone and in Combination
|
|
|
|
Abstract
|
|
|
In vitro activities of experimental antifungal agents were studied to determine the minimum inhibitory concentrations and possible drug interaction in combination of amphotericin B/ketocoazole, amphotericin B/miconazole, ketoconazole/miconazole, ketoconazole/rifampicin and miconazole/rifampicin.
The minimum inhibitory concentrations of 5 experimental antifungal agents for these strains were ranged as amphotericin B; 0.39 mcg/§¢-1.56mcg/§¢, 5-fluorocytosine; 0.25mcg/§¢-6.25mcg/§¢, ketoconazole; 0.047mcg/§¢-0.0094mcg/§¢, miconazole; 0.78mcg/§¢-1.56mcg/§¢ and rifampicin; >100.0mcg/§¢. in all of the strains, ketoconazole had a greatest antifungal activity on the dilutioin basis.
When a checkerboard technique was used amphotericin B acted synergistically with ketoconazole and miconazole whereas rifampicin had no synergistic effect.
In the cases of ketoconazole (0.023mcg/§¢) and miconazol (0.39 mcg/§¢) can be found only indifferent activity.
|
|
KEYWORD
|
|
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|
|